42 related articles for article (PubMed ID: 476236)
1. Benzodiazepines in chronic schizophrenia.
Ruskin P; Averbukh I; Belmaker RH; Dasberg H
Biol Psychiatry; 1979 Jun; 14(3):557-8. PubMed ID: 476236
[No Abstract] [Full Text] [Related]
2. Beneficial antipsychotic effects of allopurinol as add-on therapy for schizophrenia: a double blind, randomized and placebo controlled trial.
Akhondzadeh S; Safarcherati A; Amini H
Prog Neuropsychopharmacol Biol Psychiatry; 2005 Feb; 29(2):253-9. PubMed ID: 15694232
[TBL] [Abstract][Full Text] [Related]
3. Adjunctive estrogen treatment in women with chronic schizophrenia: a double-blind, randomized, and placebo-controlled trial.
Akhondzadeh S; Nejatisafa AA; Amini H; Mohammadi MR; Larijani B; Kashani L; Raisi F; Kamalipour A
Prog Neuropsychopharmacol Biol Psychiatry; 2003 Sep; 27(6):1007-12. PubMed ID: 14499318
[TBL] [Abstract][Full Text] [Related]
4. Antipsychotic effect of cannabidiol.
Zuardi AW; Morais SL; Guimarães FS; Mechoulam R
J Clin Psychiatry; 1995 Oct; 56(10):485-6. PubMed ID: 7559378
[No Abstract] [Full Text] [Related]
5. [Treatment of several psychotic states with the combination of valproic acid with diazepam].
Bourguignon A; Monfort JC; de Medeiros P; Cadet B; Chaneac D
Ann Med Psychol (Paris); 1984 Nov; 142(9):1214-8. PubMed ID: 6442960
[No Abstract] [Full Text] [Related]
6. Treatment with haloperidol and diazepam alters GABA(A) receptor density in the rat brain.
McLeod MC; Sundram S; Dean B
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):560-7. PubMed ID: 18045761
[TBL] [Abstract][Full Text] [Related]
7. Coadministration of fluvoxamine increases serum concentrations of haloperidol.
Daniel DG; Randolph C; Jaskiw G; Handel S; Williams T; Abi-Dargham A; Shoaf S; Egan M; Elkashef A; Liboff S
J Clin Psychopharmacol; 1994 Oct; 14(5):340-3. PubMed ID: 7806690
[TBL] [Abstract][Full Text] [Related]
8. The AMDP system in international clinical trials: a double-blind comparison of fluperlapine and haloperidol.
Woggon B; Linden M; Beckmann H; Krebs E; Küfferle B; Müller-Oerlinghausen B; Pflug B; Schied HW
Psychopharmacol Bull; 1986; 22(1):47-51. PubMed ID: 2873619
[No Abstract] [Full Text] [Related]
9. [A double-blind study of metoclopramide in the treatment of schizophrenia and determination of prolactin].
Gu SF
Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1992 Dec; 25(6):328-30, 382. PubMed ID: 1304992
[TBL] [Abstract][Full Text] [Related]
10. A 12-week, double-blind, placebo-controlled trial of donepezil as an adjunct to haloperidol for treating cognitive impairments in patients with chronic schizophrenia.
Lee BJ; Lee JG; Kim YH
J Psychopharmacol; 2007 Jun; 21(4):421-7. PubMed ID: 17092979
[TBL] [Abstract][Full Text] [Related]
11. Zotepine vs. haloperidol in paranoid schizophrenia: a double-blind trial.
Fleischhacker WW; Barnas C; Stuppäck CH; Unterweger B; Miller C; Hinterhuber H
Psychopharmacol Bull; 1989; 25(1):97-100. PubMed ID: 2570438
[No Abstract] [Full Text] [Related]
12. Antipsychotic effects of verapamil in schizophrenia.
Price WA
Hillside J Clin Psychiatry; 1987; 9(2):225-30. PubMed ID: 3323023
[TBL] [Abstract][Full Text] [Related]
13. Long-term efficacy and safety comparison of sertindole and haloperidol in the treatment of schizophrenia. The Sertindole Study Group.
Daniel DG; Wozniak P; Mack RJ; McCarthy BG
Psychopharmacol Bull; 1998; 34(1):61-9. PubMed ID: 9564200
[TBL] [Abstract][Full Text] [Related]
14. Flupenthixol in chronic schizophrenic inpatients: a controlled comparison with haloperidol.
Ehmann TS; Delva NJ; Beninger RJ
J Clin Psychopharmacol; 1987 Jun; 7(3):173-5. PubMed ID: 3298328
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of tiospirone vs. haloperidol and thioridazine in a double-blind, placebo-controlled trial.
Borison RL; Sinha D; Haverstock S; McLarnon MC; Diamond BI
Psychopharmacol Bull; 1989; 25(2):190-3. PubMed ID: 2574893
[No Abstract] [Full Text] [Related]
16. [Decompensated "anorexia" at age 52--diagnosis of schizophrenia 30 years later].
Hoffmann-Richter U
Psychiatr Prax; 1999 Mar; 26(2):97-8. PubMed ID: 10226306
[No Abstract] [Full Text] [Related]
17. Blood levels of haloperidol and clinical outcome in schizophrenia.
Doddi S; Rifkin A; Karajgi B; Cooper T; Borenstein M
J Clin Psychopharmacol; 1994 Jun; 14(3):187-95. PubMed ID: 8027415
[TBL] [Abstract][Full Text] [Related]
18. A multicenter controlled trial in phobic-obsessive psychoneurosis. The effect of chlorimipramine and of its combinations with haloperidol and diazepam.
Cassano GB; Castrogiovanni P; Mauri M; Rutigliano G; Pirro R; Cerone G; Nielsen NP; Reitano S; Guidotti N; Bedarida D; Marchetti FP; Catalano A; Benecchi MV; Amabile G; Zanasi M; Pugliese L; Rocco ML; Balestrieri A; Tansella M; Burti L; Pariante F
Prog Neuropsychopharmacol; 1981; 5(2):129-38. PubMed ID: 7022513
[No Abstract] [Full Text] [Related]
19. Drug treatment of adolescent tiqueurs. A double-blind trial of Diazepam and Haloperidol.
Connell PH; Corbett JA; Horne DJ; Mathews AM
Br J Psychiatry; 1967 Apr; 113(497):375-81. PubMed ID: 5340559
[No Abstract] [Full Text] [Related]
20. Diazepam in long-term chronic schizophrenia.
Borelli N; Marjerrison G
Am J Psychiatry; 1966 May; 122(11):1292-3. PubMed ID: 5325570
[No Abstract] [Full Text] [Related]
[Next] [New Search]
